NDC66336-0031-20 — CIPROFLOXACIN TABLETS

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC66336-0031-20: CIPROFLOXACIN TABLETS.

The CIPROFLOXACIN TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: PRESERVE IN TIGHT, LIGHT-RESISTANT CONTAINERS, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 20.000 TABLETS, active_medicament_medicinal_strength: 500.000 MILLIGRAMS CIPROFLOXACIN ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-511-7526, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC66336-0031-20

NSN: 6505-01-511-7526
FSC: 6505 — Drugs and Biologicals
CAGE: 1ZET5 — CENTERS FOR DISEASE CONTROL AND PREVENTION DBA CDC (USA)

SPECIFICATIONS

administration	ORAL
special_features	PRESERVE IN TIGHT, LIGHT-RESISTANT CONTAINERS
primary_container_type	BOTTLE
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	20.000 TABLETS
active_medicament_medicinal_strength	500.000 MILLIGRAMS CIPROFLOXACIN ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	CIPROFLOXACIN TABLETS USP 500MG BT 20S
american_hospital_formulary_service_classification_number	082200
NSN	6505-01-511-7526

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: ORAL

•

PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS

•

SUPPLEMENTARY FEATURES: CIPROFLOXACIN TABLETS 500MG, 20S, INDIVIDUAL BOTTLES FOR DISPENSING TO ONE PATIENT. NSN REPRESENTS A PACKAGE SIZE PREPARED BY REPACKING BULK MATERIEL. NSN CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKED DOSAGE FORM. NSN IS NOT PROCURABLE. DO NOT REQUISITION THIS NSN FOR CIPROFLOXACIN TABLETS, 500MG 20S PACKAGE

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200

TECHNICAL CHARACTERISTICS

ADMINISTRATION	ORAL
PRIMARY CONTAINER CONTENT QUANTITY	20.000 TABLETS
SUPPLEMENTARY FEATURES	CIPROFLOXACIN TABLETS 500MG, 20S, INDIVIDUAL BOTTLES FOR DISPENSING TO ONE PATIENT. NSN REPRESENTS A PACKAGE SIZE PREPARED BY REPACKING BULK MATERIEL. NSN CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKED DOSAGE FORM. NSN IS NOT PROCURABLE. DO NOT REQUISITION THIS NSN FOR CIPROFLOXACIN TABLETS, 500MG 20S PACKAGE
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	PRESERVE IN TIGHT, LIGHT-RESISTANT CONTAINERS
PART NAME ASSIGNED BY CONTROLLING AGENCY	CIPROFLOXACIN TABLETS USP 500MG BT 20S
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER	082200
ACTIVE MEDICAMENT MEDICINAL STRENGTH	500.000 MILLIGRAMS CIPROFLOXACIN ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

03-1431Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC66336-0031-20?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC66336-0031-20?

NDC66336-0031-20 is a CIPROFLOXACIN TABLETS.

What parts can replace NDC66336-0031-20?

There is 1 known substitute for NDC66336-0031-20: 03-1431. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC66336-0031-20?

NDC66336-0031-20 is cataloged in the U.S. Government catalog under NSN 6505-01-511-7526. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC66336-0031-20 — CIPROFLOXACIN TABLETS

Request a Quote — NDC66336-0031-20